EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Case Report of an ABO-Matched Post-Hematopoietic Stem Cell Transplant-Associated Autoimmune Hemolytic Anemia: A Diagnostic and Therapeutic Challenge

Owen Dan Luo, Angelo Rizzolo, Patricia Pelletier, Gizelle Popradi

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.02.003 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Owen Dan Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, QC. Electronic address: owen.luo@mail.mcgill.ca. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, ABO Blood-Group System, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune hemolytic anemia (AIHA) is a rare complication of ABO-matched hematopoietic stem cell transplantation (HSCT). Post-HSCT AIHA is diagnosed by a positive hemolysis laboratory work-up and positive direct antiglobulin testing with usually a pan-reactive antibody in indirect antiglobulin testing. In this case report, we describe the diagnosis of post-HSCT AIHA in a 62-year-old male patient and its management with combined immunosuppressive therapy with steroids, rituximab, and intravenous immunoglobulin to achieve transfusion independence and disease remission. Post-HSCT AIHA is generally refractory to treatment but this case highlights the role of combination immunosuppressive therapies to maximize the likelihood of transfusion independence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Hemolytic, AutoimmuneABO Blood-Group SystemHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedImmunosuppressive AgentsRituximabImmunoglobulins, IntravenousAntibodies, Monoclonal, Murine-DerivedTreatment Outcome

Substanzen

ABO Blood-Group SystemImmunosuppressive AgentsRituximabImmunoglobulins, IntravenousAntibodies, Monoclonal, Murine-Derived

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, McGill University, Montreal, QC. Electronic address: owen.luo@mail.mcgill.ca.
  • Faculty of Medicine and Health Sciences, McGill University, Montreal, QC.
  • Division of Hematology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, QC.

Zitieren

APA

Luo, O. D., Rizzolo, A., Pelletier, P., & Popradi, G. (2025). Case Report of an ABO-Matched Post-Hematopoietic Stem Cell Transplant-Associated Autoimmune Hemolytic Anemia: A Diagnostic and Therapeutic Challenge. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.02.003

Vancouver

Luo OD, Rizzolo A, Pelletier P, Popradi G. Case Report of an ABO-Matched Post-Hematopoietic Stem Cell Transplant-Associated Autoimmune Hemolytic Anemia: A Diagnostic and Therapeutic Challenge. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.02.003

BibTeX
@article{Luo2025,
  author = {Luo, Owen Dan and Rizzolo, Angelo and Pelletier, Patricia and Popradi, Gizelle},
  title = {Case Report of an ABO-Matched Post-Hematopoietic Stem Cell Transplant-Associated Autoimmune Hemolytic Anemia: A Diagnostic and Therapeutic Challenge},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.02.003}
}
Kostenlos starten →